Commerce Dashboard

Lotus Eye Hospital and Institute

Go Back

Lotus Eye Hospital and Institute

  • 25 years of operations
  • Introduced stitchless phacoemulsification surgery for cataract
  • Introduced no injection phaco surgery
  • Introduced multi scan lasik for the first time in India

Lotus Eye Hospital and Institute has been catering its valued added super specialty services to the society since 1993. Lotus always imports peer approved technologies from across the world. Lotus is a listed corporate eye hospital in India with seven state-of-the-art Centers in Tamil Nadu and Kerala.

Dr S K Sundramoorthy and his team of ophthalmic experts, who are highly qualified with vast experience, offer comprehensive eye care to hundreds of patients daily at our state-of-the-art hospitals in Coimbatore, Tirupur, Salem, Mettupalayam and Cochin in South India.

LOTUS is known for its excellence in ophthalmic services with personalized care and is committed to pioneering in the technological revolution in eye care and rendering service to thousands of patients from across the globe to see the world better than ever before.

It serves with super specialty comprehensive eye care consisting of modern cataract surgery, advanced LASIK procedures including bladeless lasik, ICL procedures, all varieties of corneal transplants, medical and surgical retinal services, state-of-the-art contact lens clinic, orbital and oculoplasty department, glaucoma care, neuro ophthalmology and uvea clinics.


Lotus Eye Hospital and Institute: 25 years of dedicated quality service

2014 BEACONS - The certificate is to recognize for exemplary commitment and impactful positive contribution to Tamil Nadu
2012 Life Time Achievement Award to Dr S K Sundramoorthy by the Tamil Nadu Dr M G R Medical University
2006 Limca Book of Records Award for conducting International Ophthalmic Conference on Arabian Sea
2002 Dr Sivareddy Award for Best paper in Kerala Ophthalmic Conference
1993 Best President of Lions Club, Coimbatore
The Healthcare industry size is estimated to reach US$ 193.83 billion by 2020 and US$ 372 billion by 2022.